Celiac Disease and Type 1 Diabetes in Adults: Is This a High-Risk Group for Screening?

Canadian Journal of Diabetes

Volumn 39, Issue 6, 2015, Pages 513-519

  DeMelo, Emilia N ^a   McDonald, Charlotte ^b   Saibil, Fred ^c   Marcon, Margaret A ^a   Mahmud, Farid H ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Celiac disease; Gluten free diet; Mortality risk; Nephropathy; Retinopathy; Type 1 diabetes

Indexed keywords

ADULT; BONE HEALTH; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELIAC DISEASE; CLINICAL FEATURE; COMORBIDITY; DISEASE ASSOCIATION; GLYCEMIC CONTROL; HIGH RISK POPULATION; HUMAN; IMMUNOGLOBULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MICROANGIOPATHY; MORTALITY; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; PREVALENCE; QUALITY OF LIFE; REVIEW; SCREENING TEST; COMPLICATION; MASS SCREENING; RISK FACTOR;

ADULT; CELIAC DISEASE; DIABETES MELLITUS, TYPE 1; HUMANS; MASS SCREENING; RISK FACTORS;

EID: 84946493177     PISSN: 14992671     EISSN: 23523840     Source Type: Journal    
DOI: 10.1016/j.jcjd.2015.06.006     Document Type: Review

References (93)

1. Sud S., Marcon M., Assor E., et al. Celiac disease and pediatric type 1 diabetes: Diagnostic and treatment dilemmas. Int J Pediatr Endocrinol 2010, 1-15. 161285.
2. Smyth D.J., Plagnol V., Walker N.M., et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008, 359:2767-2777.
3. Barker J.M. Clinical review: Type 1 diabetes-associated autoimmunity: Natural history, genetic associations, and screening. J Clin Endocrinol Metab 2006, 91:1210-1217.
4. Rubio-Tapia A., Kyle R.A., Kaplan E.L., et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009, 137:88-93.
5. Freeman H.J. Detection of adult celiac disease with duodenal screening biopsies over a 30-year period. Can J Gastroenterol 2013, 27:405-408.
6. Ludvigsson J.F., Rubio-Tapia A., van Dyke C.T., et al. Increasing incidence of celiac disease in a North American population. Am J Gastroenteroly 2013, 108:818-824.
7. Dabelea D., Mayer-Davis E.J., Saydah S., et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014, 311:1778-1786.
8. The DIAMOND Project Group Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006, 23:857-866.
9. Bakker S.F., Tushuizen M.E., Stokvis-Brantsma W.H., et al. Frequent delay of coeliac disease diagnosis in symptomatic patients with type 1 diabetes mellitus: Clinical and genetic characteristics. Eur J Intern Med 2013, 24:456-460.
10. Tiberti C., Panimolle F., Bonamico M., et al. Long-standing type 1 diabetes: Patients with adult-onset develop celiac-specific immunoreactivity more frequently than patients with childhood-onset diabetes, in a disease duration-dependent manner. Acta Diabetol 2014, 51(4):675-678.
11. Page S.R., Lloyd C.A., Hill P.G., et al. The prevalence of coeliac disease in adult diabetes mellitus. QJM 1994, 87:631-637.
12. Cronin C.C., Feighery A., Ferriss J.B., et al. High prevalence of celiac disease among patients with insulin-dependent (type 1) diabetes mellitus. Am J Gastroenterol 1997, 92:2210-2212.
13. Vicuna Arregui M., Zozaya Urmeneta J.M., Martinez de Esteban J.P., et al. Study of celiac disease in adults with type 1 diabetes mellitus. Gastroenterol Hepatol 2010, 33:6-11.
14. Sjoberg K., Eriksson K.F., Bredberg A., et al. Screening for coeliac disease in adult insulin-dependent diabetes mellitus. J Intern Med 1998, 243:133-140.
15. Guvenc S., Kaymakoglu S., Gurel N., et al. The prevalence of manifest and latent celiac disease in type 1 diabetes mellitus. Turk J Gastroenterol 2002, 13:103-107.
16. Collin P., Salmi J., Hallstrom O., et al. High frequency of coeliac disease in adult patients with type-I diabetes. Scand J Gastroenterol 1989, 24:81-84.
17. Aygun C., Uraz S., Damci T., et al. Celiac disease in an adult Turkish population with type 1 diabetes mellitus. Dig Dis Sci 2005, 50:1462-1466.
18. Sategna-Guidetti C., Grosso S., Pulitano R., et al. Celiac disease and insulin-dependent diabetes mellitus: Screening in an adult population. Dig Dis Sci 1994, 39:1633-1637.
19. Remes-Troche J.M., Rios-Vaca A., Ramirez-Iglesias M.T., et al. High prevalence of celiac disease in Mexican Mestizo adults with type 1 diabetes mellitus. J Clin Gastroenterol 2008, 42:460-465.
20. Talal A.H., Murray J.A., Goeken J.A., Sivitz W.I. Celiac disease in an adult population with insulin-dependent diabetes mellitus: Use of endomysial antibody testing. Am J Gastroenterol 1997, 92:1280-1284.
21. Rensch M.J., Merenich J.A., Lieberman M., et al. Gluten-sensitive enteropathy in patients with insulin-dependent diabetes mellitus. Ann Intern Med 1996, 124:564-567.
22. Mahmud F.H., Murray J.A., Kudva Y.C., et al. Celiac disease in type 1 diabetes mellitus in a North American community: Prevalence, serologic screening, and clinical features. Mayo Clin Proc 2005, 80:1429-1434.
23. Depczynski B. Coeliac disease and its relation to glycaemic control in adults with type 1 diabetes mellitus. Diabetes Res Clin Pract 2008, 79:e10.
24. American Diabetes Association - ADA Standards of medical care in diabetes: 2015. Diabetes Care 2015, 28:S1-S94.
25. Hill I.D., Dirks M.H., Liptak G.S., et al. Guideline for the diagnosis and treatment of celiac disease in children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005, 40:1-19.
26. Rubio-Tapia A., Hill I.D., Kelly C.P., et al. ACG clinical guidelines: Diagnosis and management of celiac disease. Am J Gastroenterol 2013, 108:656-676. quiz 677.
27. Wherrett D., Huot C., Mitchell B., Pacaud D. Type 1 diabetes in children and adolescents. Can J Diabetes 2013, 37(Suppl 1):S153-S162.
28. International Diabetes Federation Other complications and associated conditions. Global IDF/ISPAD guidelines for diabetes in childhood and adolescence 2011, 124-128.
29. Simpson S.M., Ciaccio E.J., Case S., et al. Celiac disease in patients with type 1 diabetes: Screening and diagnostic practices. Diabetes Educ 2013, 39:532-540.
30. Tiberti C., Panimolle F., Bonamico M., et al. IgA anti-transglutaminase autoantibodies at type 1 diabetes onset are less frequent in adult patients and are associated with a general celiac-specific lower immune response in comparison with nondiabetic celiac patients at diagnosis. Diabetes Care 2012, 35:2083-2085.
31. Egner W., Shrimpton A., Sargur R., et al. ESPGHAN guidance on coeliac disease 2012: Multiples of ULN for decision making do not harmonise assay performance across centres. J Pediatr Gastroenterol Nutr 2012, 55:733-735.
32. Bruins M.J. The clinical response to gluten challenge: A review of the literature. Nutrients 2013, 5:4614-4641.
33. Viljamaa M., Collin P., Huhtala H., et al. Is coeliac disease screening in risk groups justified? A fourteen-year follow-up with special focus on compliance and quality of life. Aliment Pharmacol Ther 2005, 22:317-324.
34. Margoni D., Chouliaras G., Duscas G., et al. Bone health in children with celiac disease assessed by dual x-ray absorptiometry: Effect of gluten-free diet and predictive value of serum biochemical indices. J Pediatr Gastroenterol Nutr 2012, 54:680-684.
35. Heikkila K., Pearce J., Maki M., Kaukinen K. Celiac disease and bone fractures: A systematic review and meta-analysis. J Clin Endocrinol Metab 2015, 100:25-34.
36. Fouda M.A., Khan A.A., Sultan M.S., et al. Evaluation and management of skeletal health in celiac disease: Position statement. Can J Gastroenterol 2012, 26:819-829.
37. Diniz-Santos D.R., Brandao F., Adan L., et al. Bone mineralization in young patients with type 1 diabetes mellitus and screening-identified evidence of celiac disease. Dig Dis Sci 2008, 53:1240-1245.
38. Simmons J.H., Klingensmith G.J., McFann K., et al. Impact of celiac autoimmunity on children with type 1 diabetes. J Pediatr 2007, 150:461-466.
39. Lunt H., Florkowski C.M., Cook H.B., Whitehead M.R. Bone mineral density, type 1 diabetes, and celiac disease. Diabetes Care 2001, 24:791-792.
40. Sategna-Guidetti C., Grosso S.B., Grosso S., et al. The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients. Aliment Pharmacol Ther 2000, 14:35-43.
41. Larussa T., Suraci E., Nazionale I., et al. No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. World J Gastroenterol 2012, 18:1622-1627.
42. Rakover Y., Hager H., Nussinson E., Luboshitzky R. Celiac disease as a cause of transient hypocalcemia and hypovitaminosis D in a 13-year-old girl. J Pediatr Endocrinol 1994, 7:53-55.
43. Tau C., Mautalen C., De Rosa S., et al. Bone mineral density in children with celiac disease: Effect of a gluten-free diet. Eur J Clin Nutr 2006, 60:358-363.
44. Rea F., Polito C., Marotta A., et al. Restoration of body composition in celiac children after one year of gluten-free diet. J Pediatr Gastroenterol Nutr 1996, 23:408-412.
45. Challa A., Moulas A., Cholevas V., et al. Vitamin D metabolites in patients with coeliac disease. Eur J Pediatr 1998, 157:262-263.
46. Capriles V.D., Martini L.A., Areas J.A. Metabolic osteopathy in celiac disease: Importance of a gluten-free diet. Nutr Rev 2009, 67:599-606.
47. Vereckei E., Szodoray P., Poor G., Kiss E. Genetic and immunological processes in the pathomechanism of gluten-sensitive enteropathy and associated metabolic bone disorders. Autoimmun Rev 2011, 10:336-340.
48. Taranta A., Fortunati D., Longo M., et al. Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. J Bone Miner Res 2004, 19:1112-1121.
49. Peters U., Askling J., Gridley G., et al. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003, 163:1566-1572.
50. Ludvigsson J.F., Montgomery S.M., Ekbom A., et al. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009, 302:1171-1178.
51. Grainge M.J., West J., Card T.R., Holmes G.K. Causes of death in people with celiac disease spanning the pre- and post-serology era: A population-based cohort study from Derby, UK. Am J Gastroenterol 2011, 106:933-939.
52. Abdul Sultan A., Crooks C.J., Card T., et al. Causes of death in people with coeliac disease in England compared with the general population: A competing risk analysis. Gut 2014, 64(8):1220-1226.
53. Ludvigsson J.F., West J., Card T., Appelros P. Risk of stroke in 28,000 patients with celiac disease: A nationwide cohort study in Sweden. J Stroke Cerebrovasc Dis 2012, 21:860-867.
54. Ludvigsson J.F., James S., Askling J., et al. Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease. Circulation 2011, 123:483-490.
55. Emilsson L., Carlsson R., Holmqvist M., et al. The characterisation and risk factors of ischaemic heart disease in patients with coeliac disease. Aliment Pharmacol Ther 2013, 37:905-914.
56. De Marchi S., Chiarioni G., Prior M., Arosio E. Young adults with coeliac disease may be at increased risk of early atherosclerosis. Aliment Pharmacol Ther 2013, 38:162-169.
57. Sari C., Bayram N.A., Dogan F.E., et al. The evaluation of endothelial functions in patients with celiac disease. Echocardiography 2012, 29:471-477.
58. Welander A., Prutz K.G., Fored M., Ludvigsson J.F. Increased risk of end-stage renal disease in individuals with coeliac disease. Gut 2012, 61:64-68.
59. Ludvigsson J.F., Montgomery S.M., Olen O., et al. Coeliac disease and risk of renal disease-a general population cohort study. Nephrol Dial Transplant 2006, 21:1809-1815.
60. Soedamah-Muthu S.S., Fuller J.H., Mulnier H.E., et al. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia 2006, 49:660-666.
61. Torn C., Ingemansson S., Lindblad U., Gudbjornsdottir S. Excess mortality in middle-aged men with diabetes aged 15-34 years at diagnosis. Acta Diabetol 2011, 48:197-202.
62. Mollazadegan K., Sanders D.S., Ludvigsson J., Ludvigsson J.F. Long-term coeliac disease influences risk of death in patients with type 1 diabetes. J Intern Med 2013, 274:273-280.
63. Rohrer T.R., Wolf J., Liptay S., et al. Microvascular complications in childhood-onset type 1 diabetes and celiac disease: A multicenter longitudinal analysis of 56,514 patients from the German-Austrian DPV database. Diabetes Care 2015, 38(5):801-807.
64. Mollazadegan K., Fored M., Lundberg S., et al. Risk of renal disease in patients with both type 1 diabetes and coeliac disease. Diabetologia 2014, 57:1339-1345.
65. Mollazadegan K., Kugelberg M., Montgomery S.M., et al. A population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease. Diabetes Care 2013, 36:316-321.
66. Leeds J.S., Hopper A.D., Hadjivassiliou M., et al. High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care 2011, 34:2158-2163.
67. Skovbjerg H., Tarnow L., Locht H., Parving H.H. The prevalence of coeliac disease in adult Danish patients with type 1 diabetes with and without nephropathy. Diabetologia 2005, 48:1416-1417.
68. Pitocco D., Giubilato S., Martini F., et al. Combined atherogenic effects of celiac disease and type 1 diabetes mellitus. Atherosclerosis 2011, 217:531-535.
69. Rybak A., Cukrowska B., Socha J., Socha P. Long-term follow up of celiac disease: Is atherosclerosis a problem?. Nutrients 2014, 6:2718-2729.
70. Lammers K.M., Khandelwal S., Chaudhry F., et al. Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease. Immunology 2011, 132:432-440.
71. Lammi A., Arikoski P., Vaarala O., et al. Increased peripheral blood CD4+ T cell responses to deamidated but not to native gliadin in children with coeliac disease. Clin Exp Immunol 2012, 168:207-214.
72. Bjorck S., Lindehammer S.R., Fex M., Agardh D. Serum cytokine pattern in young children with screening-detected coeliac disease. Clin Exp Immunol 2015, 179:230-235.
73. Jamnik J., Garcia-Bailo B., Borchers C.H., El-Sohemy A. Gluten intake is positively associated with plasma alpha2-macroglobulin in young adults. J Nutr 2015, 145(6):1256-1262.
74. Nadalutti C.A., Korponay-Szabo I.R., Kaukinen K., et al. Celiac disease patient IgA antibodies induce endothelial adhesion and cell polarization defects via extracellular transglutaminase 2. Cell Mol Life Sci 2014, 71:1315-1326.
75. Guedj K., Khallou-Laschet J., Clement M., et al. Inflammatory micro-environmental cues of human atherothrombotic arteries confer to vascular smooth muscle cells the capacity to trigger lymphoid neogenesis. PLOS One 2014, 9:e116295.
76. Lim H., Kim Y.U., Sun H., et al. Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity 2014, 40:153-165.
77. Sjoberg V., Sandstrom O., Hedberg M., et al. Intestinal T-cell responses in celiac disease - impact of celiac disease associated bacteria. PLOS One 2013, 8:e53414.
78. Cohn A., Sofia A.M., Kupfer S.S. Type 1 diabetes and celiac disease: Clinical overlap and new insights into disease pathogenesis. Curr Diab Rep 2014, 14:517.
79. Zhang C., Xiao C., Wang P., et al. The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy. Hum Immunol 2014, 75:289-296.
80. Suzuki Y., Nakazawa M., Suzuki K., et al. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Jpn J Ophthalmol 2011, 55:256-263.
81. Bakker S.F., Tushuizen M.E., von Blomberg M.E., et al. Type 1 diabetes and celiac disease in adults: Glycemic control and diabetic complications. Acta Diabetol 2013, 50:319-324.
82. Malalasekera V., Cameron F., Grixti E., Thomas M.C. Potential reno-protective effects of a gluten-free diet in type 1 diabetes. Diabetologia 2009, 52:798-800.
83. Gopee E., van den Oever E.L., Cameron F., Thomas M.C. Coeliac disease, gluten-free diet and the development and progression of albuminuria in children with type 1 diabetes. Pediatr Diabetes 2013, 14:455-458.
84. Pham-Short A., C Donaghue K., Ambler G., et al. Early elevation of albumin excretion rate is associated with poor gluten-free diet adherence in young people with coeliac disease and diabetes. Diabet Med 2014, 31:208-212.
85. Manavalan J.S., Hernandez L., Shah J.G., et al. Serum cytokine elevations in celiac disease: Association with disease presentation. Hum Immunol 2010, 71:50-57.
86. Dickey W., Kearney N. Overweight in celiac disease: Prevalence, clinical characteristics, and effect of a gluten-free diet. Am J Gastroenterol 2006, 101:2356-2359.
87. Kabbani T.A., Goldberg A., Kelly C.P., et al. Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther 2012, 35:723-729.
88. Cheng J., Brar P.S., Lee A.R., Green P.H. Body mass index in celiac disease: Beneficial effect of a gluten-free diet. J Clin Gastroenterol 2010, 44:267-271.
89. Ukkola A., Maki M., Kurppa K., et al. Changes in body mass index on a gluten-free diet in coeliac disease: A nationwide study. Eur J Intern Med 2012, 23:384-388.
90. Zanini B., Mazzoncini E., Lanzarotto F., et al. Impact of gluten-free diet on cardiovascular risk factors: A retrospective analysis in a large cohort of coeliac patients. Dig Liver Dis 2013, 45:810-815.
91. Purnell J.Q., Hokanson J.E., Marcovina S.M., et al. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: Results from the Diabetes Control and Complications Trial. JAMA 1998, 280:140-146.
92. Capristo E., Malandrino N., Farnetti S., et al. Increased serum high-density lipoprotein-cholesterol concentration in celiac disease after gluten-free diet treatment correlates with body fat stores. J Clin Gastroenterol 2009, 43:946-949.
93. Brar P., Kwon G.Y., Holleran S., et al. Change in lipid profile in celiac disease: beneficial effect of gluten-free diet. Am J Med 2006, 119:786-790.